Continuous subcutaneous insulin infusion in neonatal diabetes mellitus.
A 1.2-kg premature baby boy with severe intrauterine growth retardation developed diabetes on d 2 of life. The computed tomography scan of the pancreas failed to show the tail, indicating agenesis of the dorsal anlage. Continuous subcutaneous insulin infusion (CSII) had been used for the subsequent 26 months. Complications, such as hypoglycemia, were minimal.
Wintergerst
Kupper A
KA
Department of Pediatric Endocrinology and Diabetes, Stanford University, Stanford Medical Center, Stanford, CA, USA.
Hargadon
Susan
S
Hsiang
Helen Y
HY
D003922:Diabetes Mellitus, Type 1 / Q000151:congenital / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007332:Insulin Infusion Systems; D008297:Male; D010179:Pancreas / Q000002:abnormalities; D016896:Treatment Outcome